Avelumab as neoadjuvant therapy in subjects with urothelial muscle invasive bladder cancers
Phase of Trial: Phase II
Latest Information Update: 24 Jan 2019
At a glance
- Drugs Avelumab (Primary) ; Cisplatin; Doxorubicin; Gemcitabine; Methotrexate; Paclitaxel; Vinblastine
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms AURA trial
- 14 Dec 2018 Planned number of patients changed from 220 to 183.
- 16 Mar 2018 New trial record
- 16 Feb 2018 Trial design presented at the 2018 Genitourinary Cancers Symposium.